 Peter Mourani
Concepts (494)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchopulmonary Dysplasia | 23 | 2021 | 377 | 4.690 |
Why?
| | Intensive Care Units, Pediatric | 32 | 2024 | 203 | 3.420 |
Why?
| | Heart Arrest | 19 | 2025 | 307 | 3.000 |
Why?
| | Cardiopulmonary Resuscitation | 19 | 2025 | 224 | 3.000 |
Why?
| | Respiration, Artificial | 20 | 2024 | 604 | 2.880 |
Why?
| | Pneumonia, Ventilator-Associated | 4 | 2025 | 47 | 2.080 |
Why?
| | Critical Illness | 25 | 2025 | 755 | 1.980 |
Why?
| | Hypertension, Pulmonary | 13 | 2023 | 1749 | 1.940 |
Why?
| | Infant, Premature | 17 | 2021 | 538 | 1.910 |
Why?
| | Microbiota | 9 | 2024 | 724 | 1.870 |
Why?
| | Shock, Septic | 12 | 2024 | 208 | 1.750 |
Why?
| | Respiratory Tract Infections | 7 | 2024 | 372 | 1.560 |
Why?
| | Prospective Studies | 51 | 2025 | 7069 | 1.530 |
Why?
| | Child | 100 | 2025 | 20805 | 1.490 |
Why?
| | Respiratory Insufficiency | 6 | 2024 | 311 | 1.480 |
Why?
| | Sepsis | 12 | 2023 | 569 | 1.400 |
Why?
| | Infant, Newborn | 45 | 2025 | 5740 | 1.320 |
Why?
| | Trachea | 3 | 2017 | 221 | 1.320 |
Why?
| | Infant | 55 | 2025 | 9001 | 1.170 |
Why?
| | Child, Preschool | 49 | 2025 | 10487 | 1.140 |
Why?
| | Vascular Diseases | 5 | 2020 | 232 | 1.090 |
Why?
| | Premature Birth | 4 | 2021 | 310 | 0.970 |
Why?
| | Critical Care | 6 | 2021 | 551 | 0.960 |
Why?
| | Lung | 10 | 2024 | 3748 | 0.960 |
Why?
| | Intubation, Intratracheal | 4 | 2024 | 238 | 0.930 |
Why?
| | Humans | 143 | 2025 | 128499 | 0.930 |
Why?
| | Echocardiography | 7 | 2021 | 624 | 0.870 |
Why?
| | Accelerometry | 1 | 2024 | 92 | 0.870 |
Why?
| | Ventricular Dysfunction, Right | 3 | 2022 | 228 | 0.870 |
Why?
| | Heart Ventricles | 2 | 2021 | 767 | 0.840 |
Why?
| | Influenza, Human | 9 | 2023 | 600 | 0.830 |
Why?
| | Noninvasive Ventilation | 1 | 2024 | 49 | 0.820 |
Why?
| | Intensive Care Units | 10 | 2024 | 735 | 0.810 |
Why?
| | RNA, Ribosomal, 16S | 4 | 2021 | 522 | 0.770 |
Why?
| | Quality of Life | 13 | 2024 | 2688 | 0.760 |
Why?
| | Ventricular Function, Right | 2 | 2021 | 275 | 0.730 |
Why?
| | Respiratory Syncytial Virus Infections | 3 | 2019 | 119 | 0.730 |
Why?
| | Male | 72 | 2025 | 63045 | 0.720 |
Why?
| | Bacteria | 6 | 2025 | 817 | 0.710 |
Why?
| | Patient Discharge | 13 | 2024 | 854 | 0.700 |
Why?
| | Female | 75 | 2025 | 68268 | 0.690 |
Why?
| | Adolescent | 46 | 2025 | 20304 | 0.680 |
Why?
| | Tobacco Smoke Pollution | 1 | 2023 | 229 | 0.670 |
Why?
| | Epinephrine | 4 | 2024 | 140 | 0.650 |
Why?
| | Aftercare | 5 | 2024 | 206 | 0.610 |
Why?
| | Nutritional Support | 1 | 2017 | 32 | 0.570 |
Why?
| | Respiratory Tract Diseases | 1 | 2019 | 148 | 0.560 |
Why?
| | Echocardiography, Doppler | 3 | 2018 | 108 | 0.560 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2017 | 104 | 0.550 |
Why?
| | Patient Readmission | 3 | 2024 | 665 | 0.540 |
Why?
| | Gestational Age | 7 | 2021 | 871 | 0.540 |
Why?
| | Metagenomics | 6 | 2025 | 156 | 0.520 |
Why?
| | Respiratory Syncytial Viruses | 2 | 2013 | 52 | 0.520 |
Why?
| | Risk Factors | 21 | 2024 | 9737 | 0.510 |
Why?
| | Coinfection | 3 | 2022 | 131 | 0.500 |
Why?
| | Pulmonary Artery | 4 | 2024 | 1031 | 0.490 |
Why?
| | Echocardiography, Doppler, Pulsed | 1 | 2015 | 14 | 0.490 |
Why?
| | Energy Intake | 1 | 2017 | 454 | 0.470 |
Why?
| | Nitric Oxide | 6 | 2022 | 881 | 0.460 |
Why?
| | Retrospective Studies | 28 | 2025 | 14472 | 0.450 |
Why?
| | Infant, Extremely Low Birth Weight | 1 | 2014 | 20 | 0.450 |
Why?
| | Paramyxoviridae Infections | 1 | 2013 | 11 | 0.440 |
Why?
| | Chlorides | 3 | 2020 | 137 | 0.440 |
Why?
| | Metapneumovirus | 1 | 2013 | 13 | 0.440 |
Why?
| | Myocardial Contraction | 1 | 2015 | 334 | 0.430 |
Why?
| | Pneumonia, Bacterial | 2 | 2025 | 112 | 0.430 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2014 | 99 | 0.430 |
Why?
| | Proteomics | 5 | 2024 | 1018 | 0.430 |
Why?
| | Oxygen | 4 | 2024 | 901 | 0.420 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2015 | 141 | 0.420 |
Why?
| | Exercise | 1 | 2024 | 1918 | 0.420 |
Why?
| | Brain Injuries, Traumatic | 3 | 2023 | 337 | 0.400 |
Why?
| | Lung Diseases | 2 | 2010 | 715 | 0.400 |
Why?
| | Peripheral Vascular Diseases | 1 | 2013 | 102 | 0.390 |
Why?
| | Pulmonary Embolism | 2 | 2012 | 209 | 0.390 |
Why?
| | Bacterial Infections | 3 | 2023 | 235 | 0.390 |
Why?
| | Energy Metabolism | 1 | 2017 | 833 | 0.380 |
Why?
| | Ventricular Function, Left | 1 | 2015 | 524 | 0.380 |
Why?
| | Denys-Drash Syndrome | 1 | 2011 | 4 | 0.370 |
Why?
| | Drug Resistance, Bacterial | 2 | 2025 | 176 | 0.370 |
Why?
| | Embolectomy | 1 | 2011 | 13 | 0.370 |
Why?
| | Venous Thromboembolism | 2 | 2012 | 283 | 0.360 |
Why?
| | Bereavement | 2 | 2021 | 50 | 0.360 |
Why?
| | Ventricular Dysfunction, Left | 2 | 2020 | 383 | 0.360 |
Why?
| | High-Throughput Nucleotide Sequencing | 3 | 2025 | 487 | 0.350 |
Why?
| | Biomarkers | 10 | 2024 | 3893 | 0.350 |
Why?
| | Influenza A virus | 3 | 2020 | 100 | 0.350 |
Why?
| | Cardiopulmonary Bypass | 2 | 2025 | 192 | 0.340 |
Why?
| | Proteome | 2 | 2024 | 432 | 0.340 |
Why?
| | Wilms Tumor | 1 | 2011 | 77 | 0.340 |
Why?
| | Vasodilator Agents | 3 | 2021 | 324 | 0.340 |
Why?
| | Milrinone | 2 | 2021 | 29 | 0.340 |
Why?
| | Health Resources | 5 | 2024 | 113 | 0.330 |
Why?
| | Practice Guidelines as Topic | 1 | 2017 | 1490 | 0.330 |
Why?
| | Acute Kidney Injury | 4 | 2021 | 779 | 0.330 |
Why?
| | Logistic Models | 7 | 2024 | 1980 | 0.320 |
Why?
| | Coronary Care Units | 2 | 2018 | 16 | 0.300 |
Why?
| | Water-Electrolyte Imbalance | 2 | 2020 | 40 | 0.300 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 2008 | 85 | 0.300 |
Why?
| | Caregivers | 4 | 2024 | 813 | 0.300 |
Why?
| | Infant, Extremely Premature | 2 | 2020 | 60 | 0.300 |
Why?
| | Sulfones | 1 | 2008 | 108 | 0.290 |
Why?
| | Multiple Organ Failure | 3 | 2023 | 122 | 0.290 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 2 | 2022 | 222 | 0.290 |
Why?
| | Hernia, Diaphragmatic | 1 | 2008 | 69 | 0.290 |
Why?
| | Heparitin Sulfate | 2 | 2024 | 41 | 0.280 |
Why?
| | Heart Diseases | 2 | 2023 | 347 | 0.280 |
Why?
| | Administration, Inhalation | 5 | 2022 | 661 | 0.280 |
Why?
| | Cohort Studies | 13 | 2022 | 5402 | 0.270 |
Why?
| | Length of Stay | 5 | 2025 | 1119 | 0.270 |
Why?
| | Staphylococcus | 2 | 2017 | 74 | 0.270 |
Why?
| | Kidney Neoplasms | 1 | 2011 | 350 | 0.270 |
Why?
| | Quality Improvement | 3 | 2022 | 1097 | 0.270 |
Why?
| | Research Design | 4 | 2022 | 1036 | 0.270 |
Why?
| | Extracorporeal Membrane Oxygenation | 2 | 2021 | 281 | 0.260 |
Why?
| | Anti-Bacterial Agents | 5 | 2025 | 1705 | 0.260 |
Why?
| | Piperazines | 1 | 2008 | 333 | 0.260 |
Why?
| | Staphylococcal Infections | 2 | 2022 | 392 | 0.250 |
Why?
| | Time Factors | 10 | 2024 | 6506 | 0.250 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2008 | 203 | 0.250 |
Why?
| | Follow-Up Studies | 8 | 2021 | 4874 | 0.250 |
Why?
| | Hospital Mortality | 8 | 2023 | 847 | 0.250 |
Why?
| | Cloud Computing | 1 | 2025 | 7 | 0.240 |
Why?
| | Pregnancy | 10 | 2024 | 6373 | 0.240 |
Why?
| | Bacteriological Techniques | 1 | 2025 | 68 | 0.230 |
Why?
| | Heart Bypass, Right | 1 | 2024 | 17 | 0.230 |
Why?
| | Multiplex Polymerase Chain Reaction | 1 | 2025 | 51 | 0.230 |
Why?
| | Diastole | 3 | 2019 | 148 | 0.230 |
Why?
| | Arteriovenous Malformations | 1 | 2024 | 26 | 0.230 |
Why?
| | Ribosomal Protein S6 | 1 | 2004 | 16 | 0.230 |
Why?
| | Hypercapnia | 1 | 2024 | 49 | 0.220 |
Why?
| | Arteriovenous Fistula | 1 | 2024 | 35 | 0.220 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2004 | 34 | 0.220 |
Why?
| | DEAD Box Protein 58 | 2 | 2022 | 9 | 0.220 |
Why?
| | Bradycardia | 1 | 2024 | 53 | 0.220 |
Why?
| | Pregnancy in Diabetics | 2 | 2024 | 118 | 0.220 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2004 | 418 | 0.220 |
Why?
| | Tunica Intima | 1 | 2004 | 80 | 0.220 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2024 | 126 | 0.220 |
Why?
| | Skin Pigmentation | 1 | 2024 | 45 | 0.220 |
Why?
| | Viruses | 1 | 2024 | 100 | 0.210 |
Why?
| | Pulmonary Veins | 1 | 2024 | 93 | 0.210 |
Why?
| | Oximetry | 1 | 2024 | 87 | 0.210 |
Why?
| | Feasibility Studies | 2 | 2024 | 863 | 0.210 |
Why?
| | Longitudinal Studies | 4 | 2020 | 2710 | 0.210 |
Why?
| | Respiration | 1 | 2024 | 190 | 0.210 |
Why?
| | Employment | 1 | 2024 | 167 | 0.210 |
Why?
| | Wounds and Injuries | 2 | 2021 | 707 | 0.210 |
Why?
| | Hypoxia | 3 | 2024 | 1035 | 0.200 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2004 | 168 | 0.200 |
Why?
| | Age Factors | 6 | 2021 | 3122 | 0.200 |
Why?
| | Cotinine | 1 | 2023 | 75 | 0.200 |
Why?
| | Blood Proteins | 1 | 2024 | 240 | 0.200 |
Why?
| | Pneumonia, Staphylococcal | 1 | 2022 | 20 | 0.200 |
Why?
| | Receptors, Immunologic | 2 | 2022 | 216 | 0.200 |
Why?
| | Neuroimaging | 1 | 2025 | 279 | 0.200 |
Why?
| | Hypotension | 1 | 2023 | 115 | 0.200 |
Why?
| | Fontan Procedure | 1 | 2024 | 172 | 0.200 |
Why?
| | Meconium Aspiration Syndrome | 1 | 2022 | 11 | 0.200 |
Why?
| | Virus Diseases | 1 | 2024 | 210 | 0.190 |
Why?
| | Indoles | 1 | 2025 | 372 | 0.190 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2004 | 245 | 0.190 |
Why?
| | Treatment Outcome | 11 | 2022 | 10162 | 0.190 |
Why?
| | Magnetic Resonance Imaging | 3 | 2025 | 3387 | 0.190 |
Why?
| | Protein Kinases | 1 | 2004 | 308 | 0.190 |
Why?
| | Sodium | 1 | 2022 | 202 | 0.190 |
Why?
| | United States | 12 | 2024 | 13840 | 0.190 |
Why?
| | Central Venous Catheters | 1 | 2022 | 48 | 0.190 |
Why?
| | Smoke | 1 | 2023 | 131 | 0.190 |
Why?
| | Glasgow Coma Scale | 4 | 2023 | 167 | 0.190 |
Why?
| | Central Venous Pressure | 1 | 2021 | 14 | 0.180 |
Why?
| | Prone Position | 1 | 2021 | 30 | 0.180 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2022 | 68 | 0.180 |
Why?
| | Capnography | 1 | 2021 | 14 | 0.180 |
Why?
| | Young Adult | 10 | 2024 | 12349 | 0.180 |
Why?
| | Shock | 1 | 2022 | 92 | 0.180 |
Why?
| | Thoracic Injuries | 1 | 2021 | 55 | 0.180 |
Why?
| | ADAMTS4 Protein | 1 | 2020 | 15 | 0.180 |
Why?
| | Common Data Elements | 1 | 2020 | 12 | 0.180 |
Why?
| | Iloprost | 1 | 2021 | 45 | 0.180 |
Why?
| | Patient Positioning | 1 | 2021 | 52 | 0.180 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2022 | 132 | 0.180 |
Why?
| | Parents | 4 | 2021 | 1307 | 0.180 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2021 | 48 | 0.180 |
Why?
| | Spinal Injuries | 1 | 2021 | 52 | 0.180 |
Why?
| | Adult | 13 | 2024 | 35302 | 0.180 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2021 | 324 | 0.180 |
Why?
| | Communicable Diseases | 1 | 2022 | 145 | 0.170 |
Why?
| | Vasopressins | 1 | 2021 | 64 | 0.170 |
Why?
| | Catheterization, Central Venous | 1 | 2022 | 103 | 0.170 |
Why?
| | Socioeconomic Factors | 3 | 2020 | 1212 | 0.170 |
Why?
| | Multiple Trauma | 1 | 2021 | 101 | 0.170 |
Why?
| | Extremities | 1 | 2021 | 128 | 0.170 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2021 | 85 | 0.170 |
Why?
| | Proto-Oncogene Proteins | 1 | 2004 | 633 | 0.170 |
Why?
| | Epoprostenol | 1 | 2021 | 134 | 0.170 |
Why?
| | Angiogenic Proteins | 1 | 2020 | 16 | 0.170 |
Why?
| | Abdominal Injuries | 1 | 2021 | 117 | 0.170 |
Why?
| | Radiography, Thoracic | 1 | 2021 | 164 | 0.170 |
Why?
| | Sensitivity and Specificity | 4 | 2025 | 1817 | 0.160 |
Why?
| | Morbidity | 4 | 2022 | 301 | 0.160 |
Why?
| | Multivariate Analysis | 4 | 2018 | 1499 | 0.160 |
Why?
| | Medical Audit | 1 | 2020 | 77 | 0.160 |
Why?
| | Computational Biology | 2 | 2025 | 597 | 0.160 |
Why?
| | Mannose-Binding Lectin | 1 | 2019 | 22 | 0.160 |
Why?
| | Medical Records | 1 | 2020 | 170 | 0.160 |
Why?
| | Nervous System Diseases | 1 | 2022 | 252 | 0.160 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2020 | 89 | 0.150 |
Why?
| | Pulmonary Circulation | 2 | 2015 | 417 | 0.150 |
Why?
| | Medicine | 1 | 2020 | 117 | 0.150 |
Why?
| | Cardiotonic Agents | 1 | 2019 | 124 | 0.150 |
Why?
| | Reproducibility of Results | 4 | 2020 | 3021 | 0.150 |
Why?
| | Tertiary Care Centers | 1 | 2019 | 150 | 0.150 |
Why?
| | CRISPR-Cas Systems | 1 | 2019 | 110 | 0.150 |
Why?
| | Genetic Predisposition to Disease | 3 | 2019 | 2269 | 0.150 |
Why?
| | Cardiac Surgical Procedures | 1 | 2023 | 494 | 0.150 |
Why?
| | Adolescent Nutritional Physiological Phenomena | 1 | 2017 | 26 | 0.150 |
Why?
| | Calorimetry, Indirect | 1 | 2017 | 80 | 0.140 |
Why?
| | Toll-Like Receptor 4 | 1 | 2020 | 263 | 0.140 |
Why?
| | Diabetes, Gestational | 1 | 2022 | 308 | 0.140 |
Why?
| | Fetal Membranes, Premature Rupture | 1 | 2017 | 36 | 0.140 |
Why?
| | Academic Medical Centers | 2 | 2017 | 480 | 0.140 |
Why?
| | Renal Replacement Therapy | 1 | 2018 | 87 | 0.140 |
Why?
| | Medical Staff, Hospital | 1 | 2018 | 77 | 0.140 |
Why?
| | Gastrointestinal Microbiome | 1 | 2025 | 641 | 0.140 |
Why?
| | Chorioamnionitis | 1 | 2017 | 40 | 0.140 |
Why?
| | RNA, Bacterial | 2 | 2024 | 183 | 0.140 |
Why?
| | Blood Pressure | 4 | 2023 | 1712 | 0.140 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2017 | 67 | 0.140 |
Why?
| | Respiratory System | 1 | 2018 | 152 | 0.140 |
Why?
| | Inservice Training | 1 | 2018 | 112 | 0.140 |
Why?
| | Mutation, Missense | 1 | 2019 | 315 | 0.140 |
Why?
| | Hospitalization | 4 | 2023 | 2069 | 0.140 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2018 | 488 | 0.140 |
Why?
| | Dysbiosis | 1 | 2018 | 167 | 0.140 |
Why?
| | Motivation | 1 | 2021 | 545 | 0.140 |
Why?
| | Ultrasonography | 2 | 2025 | 712 | 0.130 |
Why?
| | Delirium | 1 | 2018 | 78 | 0.130 |
Why?
| | Chronic Disease | 3 | 2022 | 1692 | 0.130 |
Why?
| | Heart Failure | 2 | 2021 | 2145 | 0.130 |
Why?
| | Incidence | 3 | 2024 | 2638 | 0.130 |
Why?
| | Pneumonia | 1 | 2022 | 601 | 0.130 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2017 | 101 | 0.130 |
Why?
| | Heart Defects, Congenital | 2 | 2024 | 750 | 0.130 |
Why?
| | Drug Administration Schedule | 2 | 2024 | 764 | 0.130 |
Why?
| | Infant, Low Birth Weight | 2 | 2015 | 135 | 0.130 |
Why?
| | Observer Variation | 1 | 2017 | 313 | 0.130 |
Why?
| | Tandem Mass Spectrometry | 1 | 2018 | 456 | 0.130 |
Why?
| | Practice Patterns, Physicians' | 1 | 2025 | 1262 | 0.130 |
Why?
| | Hemodynamics | 3 | 2023 | 1077 | 0.130 |
Why?
| | Endothelium-Dependent Relaxing Factors | 1 | 2015 | 16 | 0.120 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2018 | 223 | 0.120 |
Why?
| | MicroRNAs | 1 | 2022 | 674 | 0.120 |
Why?
| | Survival Rate | 4 | 2024 | 1871 | 0.120 |
Why?
| | Fibroblasts | 1 | 2020 | 937 | 0.120 |
Why?
| | Hyperglycemia | 1 | 2019 | 326 | 0.120 |
Why?
| | Organ Dysfunction Scores | 3 | 2020 | 44 | 0.120 |
Why?
| | Pre-Eclampsia | 1 | 2017 | 185 | 0.120 |
Why?
| | Needs Assessment | 1 | 2017 | 356 | 0.120 |
Why?
| | Mothers | 2 | 2022 | 729 | 0.120 |
Why?
| | Severity of Illness Index | 5 | 2020 | 2719 | 0.120 |
Why?
| | Indiana | 1 | 2015 | 33 | 0.120 |
Why?
| | Delphi Technique | 3 | 2020 | 222 | 0.120 |
Why?
| | Medical Informatics | 1 | 2016 | 99 | 0.120 |
Why?
| | Hypokalemia | 1 | 2014 | 24 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2019 | 337 | 0.110 |
Why?
| | Aged | 5 | 2024 | 21976 | 0.110 |
Why?
| | Trauma Centers | 3 | 2022 | 401 | 0.110 |
Why?
| | Tomography, X-Ray Computed | 2 | 2025 | 2517 | 0.110 |
Why?
| | Bronchiolitis, Viral | 1 | 2013 | 11 | 0.110 |
Why?
| | Schools, Medical | 1 | 2015 | 130 | 0.110 |
Why?
| | RNA-Binding Proteins | 1 | 2017 | 389 | 0.110 |
Why?
| | Hospitals, Pediatric | 3 | 2023 | 509 | 0.110 |
Why?
| | Metabolomics | 1 | 2018 | 602 | 0.110 |
Why?
| | Birth Weight | 1 | 2017 | 499 | 0.110 |
Why?
| | Hyperoxia | 2 | 2024 | 87 | 0.110 |
Why?
| | Smoking | 2 | 2018 | 1459 | 0.110 |
Why?
| | Transcriptome | 3 | 2024 | 883 | 0.100 |
Why?
| | Signal Transduction | 2 | 2020 | 4825 | 0.100 |
Why?
| | Hypertension | 2 | 2019 | 1236 | 0.100 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2021 | 821 | 0.100 |
Why?
| | Risk Assessment | 5 | 2018 | 3232 | 0.100 |
Why?
| | Patient Care Team | 1 | 2018 | 598 | 0.100 |
Why?
| | Viral Load | 2 | 2024 | 449 | 0.100 |
Why?
| | Cerebral Arterial Diseases | 1 | 2012 | 49 | 0.100 |
Why?
| | Nasopharynx | 2 | 2023 | 67 | 0.100 |
Why?
| | Colorado | 4 | 2017 | 4399 | 0.100 |
Why?
| | Physicians | 1 | 2021 | 863 | 0.100 |
Why?
| | Adaptive Immunity | 2 | 2024 | 157 | 0.100 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2012 | 83 | 0.100 |
Why?
| | Risk | 2 | 2012 | 853 | 0.100 |
Why?
| | Diabetic Ketoacidosis | 1 | 2014 | 197 | 0.100 |
Why?
| | Prognosis | 4 | 2023 | 3780 | 0.100 |
Why?
| | Precision Medicine | 1 | 2016 | 386 | 0.100 |
Why?
| | Abbreviated Injury Scale | 2 | 2021 | 22 | 0.090 |
Why?
| | Polysaccharides | 1 | 2012 | 86 | 0.090 |
Why?
| | Antiphospholipid Syndrome | 1 | 2012 | 37 | 0.090 |
Why?
| | Enoxaparin | 1 | 2012 | 59 | 0.090 |
Why?
| | Suction | 1 | 2011 | 32 | 0.090 |
Why?
| | Carbon Dioxide | 2 | 2023 | 258 | 0.090 |
Why?
| | Bacterial Load | 1 | 2011 | 66 | 0.090 |
Why?
| | Immunomodulation | 1 | 2012 | 91 | 0.090 |
Why?
| | Grief | 2 | 2021 | 36 | 0.090 |
Why?
| | Fatal Outcome | 1 | 2012 | 301 | 0.090 |
Why?
| | Membrane Proteins | 1 | 2017 | 1109 | 0.090 |
Why?
| | RNA, Ribosomal | 1 | 2011 | 162 | 0.090 |
Why?
| | Pressure | 2 | 2023 | 237 | 0.090 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2017 | 564 | 0.090 |
Why?
| | Blood Coagulation Disorders | 1 | 2012 | 167 | 0.090 |
Why?
| | Anticoagulants | 2 | 2012 | 634 | 0.090 |
Why?
| | Anti-Infective Agents | 1 | 2013 | 245 | 0.090 |
Why?
| | Metagenome | 1 | 2011 | 140 | 0.090 |
Why?
| | Hypoglycemic Agents | 1 | 2019 | 1217 | 0.090 |
Why?
| | Interferons | 2 | 2022 | 192 | 0.080 |
Why?
| | Fibrinolytic Agents | 1 | 2012 | 261 | 0.080 |
Why?
| | Adrenal Cortex Hormones | 2 | 2024 | 518 | 0.080 |
Why?
| | Vitamin D | 1 | 2013 | 380 | 0.080 |
Why?
| | Intensive Care, Neonatal | 1 | 2010 | 39 | 0.080 |
Why?
| | Fetal Blood | 1 | 2012 | 317 | 0.080 |
Why?
| | Stakeholder Participation | 2 | 2020 | 77 | 0.080 |
Why?
| | Antihypertensive Agents | 1 | 2013 | 482 | 0.080 |
Why?
| | Blood Glucose | 2 | 2019 | 2092 | 0.080 |
Why?
| | Influenza Vaccines | 1 | 2014 | 532 | 0.080 |
Why?
| | Potassium | 2 | 2022 | 139 | 0.080 |
Why?
| | Sildenafil Citrate | 1 | 2008 | 59 | 0.080 |
Why?
| | Survivors | 2 | 2022 | 462 | 0.080 |
Why?
| | Pediatrics | 1 | 2016 | 1050 | 0.070 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2008 | 66 | 0.070 |
Why?
| | Surveys and Questionnaires | 4 | 2021 | 5371 | 0.070 |
Why?
| | Stem Cells | 1 | 2012 | 578 | 0.070 |
Why?
| | Pulmonary Edema | 1 | 2008 | 104 | 0.070 |
Why?
| | Purines | 1 | 2008 | 169 | 0.070 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2023 | 941 | 0.070 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2024 | 1187 | 0.070 |
Why?
| | Postoperative Complications | 1 | 2018 | 2462 | 0.070 |
Why?
| | Stroke Volume | 2 | 2021 | 589 | 0.070 |
Why?
| | Survival Analysis | 2 | 2022 | 1265 | 0.070 |
Why?
| | Diseases in Twins | 1 | 2008 | 176 | 0.070 |
Why?
| | Gene Expression | 2 | 2022 | 1455 | 0.060 |
Why?
| | Neovascularization, Physiologic | 2 | 2012 | 172 | 0.060 |
Why?
| | Indoleacetic Acids | 1 | 2025 | 8 | 0.060 |
Why?
| | Clinical Competence | 2 | 2023 | 1009 | 0.060 |
Why?
| | Phenotype | 2 | 2023 | 3051 | 0.060 |
Why?
| | Angiopoietin-2 | 1 | 2024 | 15 | 0.060 |
Why?
| | Cell Division | 2 | 2004 | 777 | 0.060 |
Why?
| | Hypocapnia | 1 | 2024 | 8 | 0.060 |
Why?
| | Whole Genome Sequencing | 1 | 2025 | 130 | 0.060 |
Why?
| | Cardiac Catheterization | 1 | 2008 | 517 | 0.060 |
Why?
| | Culture Media, Serum-Free | 1 | 2004 | 49 | 0.060 |
Why?
| | Stroke | 1 | 2012 | 1073 | 0.060 |
Why?
| | Chromones | 1 | 2004 | 45 | 0.060 |
Why?
| | Diffuse Axonal Injury | 1 | 2023 | 8 | 0.060 |
Why?
| | Cytokines | 1 | 2012 | 1994 | 0.060 |
Why?
| | Carotid Artery Injuries | 1 | 2004 | 41 | 0.050 |
Why?
| | Aorta | 2 | 2004 | 408 | 0.050 |
Why?
| | Drug Resistance, Microbial | 1 | 2024 | 68 | 0.050 |
Why?
| | Syndecan-1 | 1 | 2023 | 27 | 0.050 |
Why?
| | Disaccharides | 1 | 2023 | 18 | 0.050 |
Why?
| | Androstadienes | 1 | 2004 | 106 | 0.050 |
Why?
| | Adaptive Clinical Trials as Topic | 1 | 2023 | 20 | 0.050 |
Why?
| | Oligonucleotides, Antisense | 1 | 2004 | 106 | 0.050 |
Why?
| | Glycocalyx | 1 | 2023 | 19 | 0.050 |
Why?
| | Vasoconstrictor Agents | 1 | 2024 | 127 | 0.050 |
Why?
| | Corpus Callosum | 1 | 2023 | 66 | 0.050 |
Why?
| | Chondroitin Sulfates | 1 | 2023 | 34 | 0.050 |
Why?
| | Water-Electrolyte Balance | 1 | 2023 | 32 | 0.050 |
Why?
| | Probability | 1 | 2004 | 306 | 0.050 |
Why?
| | Morpholines | 1 | 2004 | 122 | 0.050 |
Why?
| | Catheterization | 1 | 2004 | 173 | 0.050 |
Why?
| | Proteoglycans | 1 | 2023 | 109 | 0.050 |
Why?
| | Methicillin | 1 | 2022 | 11 | 0.050 |
Why?
| | Sirolimus | 1 | 2004 | 190 | 0.050 |
Why?
| | Vascular Resistance | 1 | 2004 | 367 | 0.050 |
Why?
| | Chemotactic Factors | 1 | 2022 | 54 | 0.050 |
Why?
| | PTEN Phosphohydrolase | 1 | 2004 | 158 | 0.050 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2023 | 146 | 0.050 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2022 | 2064 | 0.050 |
Why?
| | Sodium Bicarbonate | 1 | 2022 | 37 | 0.050 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2023 | 250 | 0.050 |
Why?
| | Respiratory Function Tests | 1 | 2004 | 580 | 0.050 |
Why?
| | RNA, Viral | 2 | 2017 | 615 | 0.050 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2024 | 624 | 0.050 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2004 | 357 | 0.050 |
Why?
| | White Matter | 1 | 2023 | 134 | 0.050 |
Why?
| | Cost of Illness | 1 | 2024 | 278 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2004 | 420 | 0.050 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 63 | 0.050 |
Why?
| | Norepinephrine | 1 | 2022 | 210 | 0.050 |
Why?
| | Protein Processing, Post-Translational | 1 | 2004 | 453 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2004 | 2272 | 0.050 |
Why?
| | Neonatologists | 1 | 2021 | 6 | 0.050 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2004 | 382 | 0.050 |
Why?
| | Sequence Analysis, RNA | 1 | 2023 | 428 | 0.050 |
Why?
| | Patient Acuity | 1 | 2021 | 45 | 0.040 |
Why?
| | Influenza in Birds | 1 | 2020 | 3 | 0.040 |
Why?
| | Leukocyte Common Antigens | 1 | 2020 | 81 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2004 | 813 | 0.040 |
Why?
| | Blood Gas Analysis | 1 | 2020 | 71 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2012 | 2001 | 0.040 |
Why?
| | Stromal Cells | 1 | 2020 | 106 | 0.040 |
Why?
| | Software | 1 | 2025 | 608 | 0.040 |
Why?
| | Birds | 1 | 2020 | 83 | 0.040 |
Why?
| | Bicarbonates | 1 | 2020 | 42 | 0.040 |
Why?
| | Hematoma, Subdural | 1 | 2019 | 17 | 0.040 |
Why?
| | DNA, Bacterial | 1 | 2021 | 324 | 0.040 |
Why?
| | Endpoint Determination | 1 | 2020 | 76 | 0.040 |
Why?
| | Recurrence | 2 | 2012 | 1004 | 0.040 |
Why?
| | Skull Fractures | 1 | 2019 | 34 | 0.040 |
Why?
| | Phosphorylation | 1 | 2004 | 1686 | 0.040 |
Why?
| | Injury Severity Score | 1 | 2021 | 509 | 0.040 |
Why?
| | Dopamine | 1 | 2022 | 285 | 0.040 |
Why?
| | Radiation Exposure | 1 | 2019 | 45 | 0.040 |
Why?
| | Intracranial Hemorrhages | 1 | 2019 | 80 | 0.040 |
Why?
| | Interferon-gamma | 1 | 2022 | 761 | 0.040 |
Why?
| | Cardiac Output | 1 | 2019 | 154 | 0.040 |
Why?
| | Child Health | 1 | 2020 | 146 | 0.040 |
Why?
| | Metabolic Clearance Rate | 1 | 2019 | 108 | 0.040 |
Why?
| | Hospitals | 1 | 2023 | 637 | 0.040 |
Why?
| | Interferon-alpha | 1 | 2020 | 193 | 0.040 |
Why?
| | Immunity, Innate | 1 | 2024 | 803 | 0.040 |
Why?
| | Maternal Exposure | 2 | 2012 | 175 | 0.040 |
Why?
| | Complement Activation | 1 | 2021 | 367 | 0.040 |
Why?
| | Regression Analysis | 1 | 2021 | 982 | 0.040 |
Why?
| | American Heart Association | 1 | 2020 | 297 | 0.040 |
Why?
| | Staphylococcus aureus | 1 | 2022 | 436 | 0.040 |
Why?
| | Case-Control Studies | 2 | 2019 | 3339 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2019 | 281 | 0.040 |
Why?
| | Developmental Disabilities | 1 | 2021 | 259 | 0.040 |
Why?
| | Rats | 2 | 2004 | 5246 | 0.040 |
Why?
| | Community-Acquired Infections | 1 | 2020 | 160 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 276 | 0.040 |
Why?
| | Middle Aged | 3 | 2024 | 30923 | 0.040 |
Why?
| | Seasons | 1 | 2020 | 498 | 0.040 |
Why?
| | Guidelines as Topic | 1 | 2020 | 260 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2020 | 373 | 0.040 |
Why?
| | Protein Kinase Inhibitors | 1 | 2004 | 880 | 0.040 |
Why?
| | Animals | 5 | 2020 | 34647 | 0.040 |
Why?
| | Patient Acceptance of Health Care | 1 | 2024 | 757 | 0.040 |
Why?
| | Data Collection | 1 | 2020 | 649 | 0.040 |
Why?
| | Mortality | 1 | 2020 | 306 | 0.040 |
Why?
| | Consensus | 1 | 2020 | 610 | 0.040 |
Why?
| | Healthcare Disparities | 1 | 2024 | 579 | 0.040 |
Why?
| | Creatinine | 1 | 2019 | 480 | 0.030 |
Why?
| | Pilot Projects | 1 | 2022 | 1568 | 0.030 |
Why?
| | Genotyping Techniques | 1 | 2017 | 72 | 0.030 |
Why?
| | Causality | 1 | 2017 | 116 | 0.030 |
Why?
| | Multicenter Studies as Topic | 1 | 2018 | 286 | 0.030 |
Why?
| | Homozygote | 1 | 2017 | 193 | 0.030 |
Why?
| | Gene Expression Profiling | 2 | 2020 | 1689 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2021 | 1412 | 0.030 |
Why?
| | Calcium | 1 | 2022 | 1183 | 0.030 |
Why?
| | Extracellular Matrix | 1 | 2020 | 499 | 0.030 |
Why?
| | Point-of-Care Systems | 1 | 2018 | 146 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2004 | 4017 | 0.030 |
Why?
| | Family | 1 | 2020 | 649 | 0.030 |
Why?
| | Registries | 1 | 2023 | 1883 | 0.030 |
Why?
| | Social Class | 1 | 2018 | 258 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2017 | 378 | 0.030 |
Why?
| | Adaptation, Psychological | 1 | 2020 | 617 | 0.030 |
Why?
| | Linear Models | 1 | 2018 | 816 | 0.030 |
Why?
| | Glucocorticoids | 1 | 2020 | 573 | 0.030 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2016 | 122 | 0.030 |
Why?
| | Comorbidity | 1 | 2020 | 1541 | 0.030 |
Why?
| | Communication | 1 | 2021 | 841 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2022 | 2679 | 0.030 |
Why?
| | Proteins | 1 | 2000 | 936 | 0.030 |
Why?
| | Body Weight | 1 | 2019 | 933 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1477 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2020 | 711 | 0.030 |
Why?
| | Orthomyxoviridae | 1 | 2014 | 40 | 0.030 |
Why?
| | Child Health Services | 1 | 2016 | 185 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 1938 | 0.030 |
Why?
| | Emergency Service, Hospital | 1 | 2024 | 1900 | 0.030 |
Why?
| | Protein Binding | 1 | 2019 | 2110 | 0.020 |
Why?
| | Inflammation | 1 | 2023 | 2666 | 0.020 |
Why?
| | Databases, Factual | 1 | 2018 | 1267 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2018 | 1358 | 0.020 |
Why?
| | Depression | 1 | 2021 | 1292 | 0.020 |
Why?
| | Immune System | 1 | 2013 | 176 | 0.020 |
Why?
| | Algorithms | 1 | 2019 | 1614 | 0.020 |
Why?
| | Models, Biological | 1 | 2019 | 1698 | 0.020 |
Why?
| | Vitamin D Deficiency | 1 | 2013 | 176 | 0.020 |
Why?
| | Diagnostic Imaging | 1 | 2012 | 332 | 0.020 |
Why?
| | Electrocardiography | 1 | 2012 | 608 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 2012 | 539 | 0.020 |
Why?
| | Dietary Supplements | 1 | 2013 | 531 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2012 | 1142 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2604 | 0.020 |
Why?
| | Endothelial Cells | 1 | 2012 | 703 | 0.020 |
Why?
| | Global Health | 1 | 2008 | 330 | 0.020 |
Why?
| | Mice | 1 | 2020 | 16620 | 0.010 |
Why?
| | Embryo, Mammalian | 1 | 2000 | 226 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2000 | 522 | 0.010 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2014 | 3626 | 0.010 |
Why?
|
|
Mourani's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|